WaveMan · Form 4
Baker Bros. Advisors (GP) LLC insider trades
> Search tickers & screens ⌘K
LIVE

Baker Bros. Advisors (GP) LLC insider trades

Baker Bros. Advisors (GP) LLC has filed 30 Form 4s with the SEC that we hold, for Incyte Corp (INCY) (Director, 10% owner), Kodiak Sciences Inc. (KOD) (Director, 10% owner), Prelude Therapeutics Inc (PRLD) (Director, 10% owner) and Entrada Therapeutics, Inc. (TRDA) (10% owner), among 18 companies in all. Across all of them we count 84 purchases worth $117.0M and 2 sales worth $190.5M reported on Form 4. In the last 12 months: 12 purchases ($1.4M) and 0 sales ($0). The largest single trade was a sale of 671,976 shares of BeOne Medicines Ltd. worth $174.7M, dated 2025-02-28. The first filing on our record is dated 2021-08-13 and the latest 2026-06-25.

Incyte Corp (INCY)

Director, 10% owner · 3 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Kodiak Sciences Inc. (KOD)

Director, 10% owner · 3 filings · 24 purchases and sales
Trade dateCodeSharesValue as filedFiled
2021-08-11P, purchase reported on Form 444,700$3.8M2021-08-13
2021-08-11P, purchase reported on Form 44,500$396.0K2021-08-13
2021-08-11P, purchase reported on Form 43,723$314.2K2021-08-13
2021-08-11P, purchase reported on Form 4600$51.4K2021-08-13
2021-08-12P, purchase reported on Form 4300$25.7K2021-08-13
2021-08-12P, purchase reported on Form 44,600$397.6K2021-08-13
2021-08-12P, purchase reported on Form 46,086$535.6K2021-08-13
2021-08-13P, purchase reported on Form 421,595$1.9M2021-08-13
2021-08-13P, purchase reported on Form 416,269$1.4M2021-08-13
2021-08-13P, purchase reported on Form 4400$35.5K2021-08-13
2021-09-07P, purchase reported on Form 45,300$492.3K2021-09-09
2021-09-07P, purchase reported on Form 452,201$4.9M2021-09-09
2022-06-02P, purchase reported on Form 41,247$9.4K2022-06-06
2022-06-02P, purchase reported on Form 410,585$79.5K2022-06-06
2022-06-02P, purchase reported on Form 416,278$125.0K2022-06-06
2022-06-02P, purchase reported on Form 4138,122$1.1M2022-06-06
2022-06-03P, purchase reported on Form 413,155$104.3K2022-06-06
2022-06-03P, purchase reported on Form 41,550$12.3K2022-06-06
2022-06-03P, purchase reported on Form 49,224$73.3K2022-06-06
2022-06-03P, purchase reported on Form 478,271$622.3K2022-06-06
2022-06-06P, purchase reported on Form 4170,549$1.3M2022-06-06
2022-06-06P, purchase reported on Form 411,945$92.6K2022-06-06
2022-06-06P, purchase reported on Form 4101,315$785.2K2022-06-06
2022-06-06P, purchase reported on Form 420,108$156.4K2022-06-06

Prelude Therapeutics Inc (PRLD)

Director, 10% owner · 3 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Entrada Therapeutics, Inc. (TRDA)

10% owner · 2 filings · 18 purchases and sales
Trade dateCodeSharesValue as filedFiled
2022-06-02P, purchase reported on Form 42,364$13.8K2022-06-06
2022-06-02P, purchase reported on Form 4279$1.6K2022-06-06
2022-06-06P, purchase reported on Form 4921$5.8K2022-06-06
2022-06-06P, purchase reported on Form 47,815$49.6K2022-06-06
2022-06-06P, purchase reported on Form 426,450$169.8K2022-06-06
2022-06-06P, purchase reported on Form 43,118$20.0K2022-06-06
2025-11-10P, purchase reported on Form 42,947$21.3K2025-11-12
2025-11-10P, purchase reported on Form 4267$1.9K2025-11-12
2025-11-10P, purchase reported on Form 425,364$182.9K2025-11-12
2025-11-10P, purchase reported on Form 42,296$16.6K2025-11-12
2025-11-11P, purchase reported on Form 411,701$86.5K2025-11-12
2025-11-11P, purchase reported on Form 42,795$21.1K2025-11-12
2025-11-11P, purchase reported on Form 430,879$232.8K2025-11-12
2025-11-11P, purchase reported on Form 41,059$7.8K2025-11-12
2025-11-12P, purchase reported on Form 411,494$91.4K2025-11-12
2025-11-12P, purchase reported on Form 47,321$56.6K2025-11-12
2025-11-12P, purchase reported on Form 480,881$625.2K2025-11-12
2025-11-12P, purchase reported on Form 41,040$8.3K2025-11-12

IGMS

Director, 10% owner · 2 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Immunocore Holdings plc (IMCR)

Director · 2 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Kymera Therapeutics, Inc. (KYMR)

Director, 10% owner · 2 filings · 2 purchases and sales
Trade dateCodeSharesValue as filedFiled
2025-06-30P, purchase reported on Form 455,191$2.4M2025-06-30
2025-06-30P, purchase reported on Form 4600,309$26.4M2025-06-30

Madrigal Pharmaceuticals, INC. (MDGL)

Director · 2 filings · 26 purchases and sales
Trade dateCodeSharesValue as filedFiled
2025-08-18P, purchase reported on Form 42,460$917.3K2025-08-20
2025-08-18P, purchase reported on Form 426,704$10.0M2025-08-20
2025-08-18P, purchase reported on Form 4675$252.7K2025-08-20
2025-08-18P, purchase reported on Form 47,325$2.7M2025-08-20
2025-08-20P, purchase reported on Form 4480$182.6K2025-08-20
2025-08-20P, purchase reported on Form 45,209$2.0M2025-08-20
2025-08-20P, purchase reported on Form 4176$67.0K2025-08-20
2025-08-20P, purchase reported on Form 41,919$730.7K2025-08-20
2025-08-20P, purchase reported on Form 4873$332.7K2025-08-20
2025-08-20P, purchase reported on Form 49,477$3.6M2025-08-20
2025-08-20P, purchase reported on Form 4105$40.1K2025-08-20
2025-08-20P, purchase reported on Form 41,136$434.3K2025-08-20
2025-08-20P, purchase reported on Form 4262$100.3K2025-08-20
2025-08-20P, purchase reported on Form 42,838$1.1M2025-08-20
2025-08-20P, purchase reported on Form 4373$143.2K2025-08-20
2025-08-20P, purchase reported on Form 44,049$1.6M2025-08-20
2025-08-20P, purchase reported on Form 41,248$480.6K2025-08-20
2025-08-20P, purchase reported on Form 413,545$5.2M2025-08-20
2025-08-20P, purchase reported on Form 4409$158.3K2025-08-20
2025-08-20P, purchase reported on Form 44,441$1.7M2025-08-20
2025-08-20P, purchase reported on Form 434$13.2K2025-08-20
2025-08-20P, purchase reported on Form 4366$142.4K2025-08-20
2025-08-20P, purchase reported on Form 4231$90.1K2025-08-20
2025-08-20P, purchase reported on Form 42,506$977.1K2025-08-20
2025-08-20P, purchase reported on Form 4862$338.1K2025-08-20
2025-08-20P, purchase reported on Form 49,362$3.7M2025-08-20

Replimune Group, Inc. (REPL)

Director, 10% owner · 2 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Acadia Pharmaceuticals INC (ACAD)

Director, 10% owner · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

BLCM

10% owner · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

BeOne Medicines Ltd. (ONC)

Director · 1 filing · 2 purchases and sales
Trade dateCodeSharesValue as filedFiled
2025-02-28S, sale reported on Form 4671,976$174.7M2025-02-28
2025-02-28S, sale reported on Form 460,851$15.8M2025-02-28

Bicycle Therapeutics PLC (BCYC)

Director, 10% owner · 1 filing · 10 purchases and sales
Trade dateCodeSharesValue as filedFiled
2024-12-13P, purchase reported on Form 459,995$817.7K2024-12-17
2024-12-13P, purchase reported on Form 422,722$311.7K2024-12-17
2024-12-13P, purchase reported on Form 4244,587$3.4M2024-12-17
2024-12-13P, purchase reported on Form 452,656$726.7K2024-12-17
2024-12-13P, purchase reported on Form 4566,814$7.8M2024-12-17
2024-12-13P, purchase reported on Form 45,573$76.0K2024-12-17
2024-12-13P, purchase reported on Form 42,809$37.9K2024-12-17
2024-12-13P, purchase reported on Form 430,241$408.3K2024-12-17
2024-12-16P, purchase reported on Form 442,369$649.9K2024-12-17
2024-12-16P, purchase reported on Form 4457,631$7.0M2024-12-17

Celcuity Inc. (CELC)

10% owner · 1 filing · 4 purchases and sales
Trade dateCodeSharesValue as filedFiled
2025-09-08P, purchase reported on Form 44,212$244.4K2025-09-10
2025-09-08P, purchase reported on Form 4388$22.5K2025-09-10
2025-09-08P, purchase reported on Form 4151,524$8.5M2025-09-10
2025-09-08P, purchase reported on Form 413,976$785.7K2025-09-10

DBV Technologies S.A. (DBVT)

Director, 10% owner · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Kiniksa Pharmaceuticals International, plc (KNSA)

Director · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Neurogene Inc. (NLTX)

Director, 10% owner · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

TLIS

Director, 10% owner · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1580575) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms